Historical record - last NADAC effective date: 4/17/2024
Product Information
TADALAFIL 2.5 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.1124 per EA under NDC 16729036916. Its NADAC has been published 208 times since May 27, 2020.
FDA first approved this application on Mar 26, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729036916
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
4/17/2024
Active Ingredients
TADALAFILApproval Type
Generic (ANDA)
FDA Application
ANDA209167FDA Approved
3/26/2019
TE Code
AB1
On Market Since
3/27/2019
Pharmacological Classes
Price Statistics
The NADAC for TADALAFIL 2.5 MG TABLET has been published 208 times since May 27, 2020, and over the history we have for it it has declined 52.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1124 per EA |
|---|---|
| All-time high | $0.3319 (Aug 12, 2020) |
| All-time low | $0.1124 (Apr 17, 2024) |
| Median price | $0.1859 |
| Average price | $0.1946 |
| Largest weekly change | +50.4% (Jun 22, 2022) |
| Weeks tracked | 208 |
| Tracking since | May 27, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-36.4%
5Y
-33.4%
All
-52.4%
Last surveyed May 15, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TADALAFIL 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TADALAFIL 2.5 MG TABLET, manufactured by Accord Healthcare Inc., is $0.1124 per EA (NDC 16729036916), effective May 15, 2024.
How has the price of TADALAFIL 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for TADALAFIL 2.5 MG TABLET has declined 52.4%. It has been tracked across 208 weekly CMS publications since May 27, 2020.
What are the highest and lowest recorded NADAC prices for TADALAFIL 2.5 MG TABLET?
Since May 27, 2020, the NADAC for TADALAFIL 2.5 MG TABLET has ranged from a low of $0.1124 (Apr 17, 2024) to a high of $0.3319 (Aug 12, 2020), with a median of $0.1859 per EA.
Are there cheaper alternatives to TADALAFIL 2.5 MG TABLET?
12 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TADALAFIL 2.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TADALAFIL 2.5 MG TABLET?
TADALAFIL 2.5 MG TABLET (NDC 16729036916) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.